Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

Abouhajar, Alaa; Alcock, Lisa; Bigirumurame, Theophile; Bradley, Penny; Brown, Laura; Campbell, Ian; Del Din, Silvia; Faitg, Julie; Falkous, Gavin; Gorman, Grainne S.; Lakey, Rachel; McFarland, Robert; Newman, Jane; Rochester, Lynn; Ryan, Vicky; Smith, Hesther; Steel, Alison; Stefanetti, Renae J.; Su, Huizhong; Taylor, Robert W.; Thomas, Naomi J. P.; Tuppen, Helen; Vincent, Amy E.; Warren, Charlotte; Watson, Gillian

doi:10.1186/s13063-022-06814-8

Trials

Article metrics
Last updated: Tue, 30 Apr 2024 7:00:56 Z

Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

Access & Citations

700

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1745-6215

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com